Sort
51,593 grants matching “hepatitis”
Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in Human
$434,843Karen L Teff · Monell Chemical Senses Center · R01 · FY2011 · DK
Role of NF-kB-induce kinase (NIK) in liver diseases
$434,841Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
$434,832Chris Beyrer · Johns Hopkins University · T32 · FY2019 · AI
HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA
$434,799Yeshiva University · R01 · FY2001 · CA
Relaxin receptor agonists for treatment of liver fibrosis
$434,786Alexander I. Agoulnik · Florida International University · R01 · FY2018 · DK
Animal Core
$434,767Hidekazu Tsukamoto · University Of Southern California · P50 · FY2020 · AA
Regulation of Glucose Transport in Muscle Cells
$434,750Samuel Cushman · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Project 4: Lipoproteins and CVD risk in diabetes
$434,723Jay W Heinecke · University Of Washington · P01 · FY2022 · HL
Cellular and Molecular Biology of Inflammation and Repair
$434,697Jorge E Albina · Rhode Island Hospital · R01 · FY2007 · GM
Tagged binding agents as improved anti-toxin therapeutics
$434,631Charles Bix Shoemaker · Harvard Medical School · U54 · FY2009 · AI
Mechanisms of Polyploidy and Aneuploidy in the Liver
$434,620Andrew W Duncan · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · DK
CAMPYLOBACTOR JEJUNI CHALLENGE MODEL DEVELOPMENT: DOSE-RANGING STUDY
$434,620Beth Diane Kirkpatrick · University Of Vermont & St Agric College · M01 · FY2008 · RR
Studies of Rare Cancers
$434,550Katherine McGlynn · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Post-trial HIV Vaccines: Receptivity, Risk & Disparities
$434,542William E Cunningham · University Of California Los Angeles · R01 · FY2007 · MH
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$434,521Guisheng Song · University Of Minnesota · R01 · FY2014 · DK
Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro
$434,513Robert Heimer · Yale University · R01 · FY2014 · DA
Interaction between RNA interference and RNA editing pathways
$434,445Kazuko Nishikura · Wistar Institute · R01 · FY2012 · GM
Interaction between RNA interference and RNA editing pathways
$434,445Kazuko Nishikura · Wistar Institute · R01 · FY2011 · GM
Decreased Fat Oxidation - Metabolic Inflexibility in African-American Women
$434,382James Delany · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · DK
BMP Signaling--A Therapeutic Target in Liver Disease
$434,375Seth J Karp · Beth Israel Deaconess Medical Center · R01 · FY2010 · DK
2/4-The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopschosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
$434,374Elizabeth Clarice Verna · Columbia University Health Sciences · R01 · FY2025 · AA
Mechanisms of Polyploidy and Aneuploidy in the Liver
$434,362Andrew W Duncan · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
2/4-The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopschosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
$434,338Elizabeth Clarice Verna · Columbia University Health Sciences · R01 · FY2024 · AA
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$434,317Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE
The Role of FcRn in Echovirus Entry and Pathogenesis
$434,308Carolyn B Coyne · Duke University · R01 · FY2024 · AI